1696.HK लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 08:18):

Stats
आज की मात्रा	288 400
औसत मात्रा	654 693
बाजार मूल्य	1.89B
EPS	HKD0 ( 2024-03-21 )
अगली कमाई की तारीख	( HKD0 ) 2024-06-27
Last Dividend	HKD0.173 ( 2023-08-24 )
Next Dividend	HKD0 ( N/A )
P/E	7.62
ATR14	HKD0.0220 (0.54%)

मात्रा सहसंबंध

लंबा: 0.02 (neutral)

छोटा: 0.33 (neutral)

Signal:(50.851) Neutral

Sisram Medical Ltd सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Sisram Medical Ltd सहसंबंध - मुद्रा/वस्त्र

-0.02
( neutral )

0.59
( weak )

0.00
( neutral )

0.43
( neutral )

0.88
( strong )

-0.70
( moderate negative )

Sisram Medical Ltd वित्तीय

Annual	2023
राजस्व:	HKD359.29M
सकल लाभ:	HKD219.53M (61.10 %)
EPS:	HKD0.0674

FY	2023
राजस्व:	HKD359.29M
सकल लाभ:	HKD219.53M (61.10 %)
EPS:	HKD0.0674

FY	2022
राजस्व:	HKD354.48M
सकल लाभ:	HKD202.23M (57.05 %)
EPS:	HKD0.0862

FY	2021
राजस्व:	HKD294.29M
सकल लाभ:	HKD166.86M (56.70 %)
EPS:	HKD0.0710

Financial Reports:

No articles found.

Sisram Medical Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.157 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.173 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Sisram Medical Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.83 - Stable (3.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.100	2019-06-21
Last Dividend	HKD0.173	2023-08-24
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	HKD0.610	--
Avg. Dividend % Per Year	0.00%	--
Score	2.82	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.83
Div. Directional Score	7.58	--

Next Divdend (Est)
(2024-08-01)

HKD0.202 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3692.HK	Ex Dividend Knight	2023-09-15	Semi-Annually	0.00%
1635.HK	No Dividend Player	2023-06-30	Annually	0.00%
0683.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
2205.HK	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
1209.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0272.HK	Ex Dividend Junior	2023-09-07	Annually	0.00%
3983.HK	Ex Dividend Knight	2023-05-30	Annually	0.00%
1786.HK	Ex Dividend Junior	2023-07-04	Sporadic	0.00%
0822.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
2368.HK	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0877	1.500	8.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0513	1.200	8.29	9.95	[0 - 0.3]
returnOnEquityTTM	0.0706	1.500	-0.327	-0.490	[0.1 - 1]
payoutRatioTTM	0.334	-1.000	6.66	-6.66	[0 - 1]
currentRatioTTM	2.92	0.800	0.419	0.335	[1 - 3]
quickRatioTTM	1.925	0.800	3.38	2.71	[0.8 - 2.5]
cashRatioTTM	0.800	1.500	6.67	10.00	[0.2 - 2]
debtRatioTTM	0.0728	-1.500	8.79	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0940	2.00	9.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0757	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.0988	-1.500	9.60	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.611	1.000	3.15	3.15	[0.2 - 0.8]
operatingProfitMarginTTM	0.106	1.000	9.88	9.88	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.983	1.000	5.65	5.65	[0.2 - 2]
assetTurnoverTTM	0.586	0.800	9.43	7.54	[0.5 - 2]
Total Score				10.33

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.48	1.000	9.35	0	[1 - 100]
returnOnEquityTTM	0.0706	2.50	-0.210	-0.490	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0757	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	34.32	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0940	2.00	9.97	10.00	[0 - 30]
payoutRatioTTM	0.334	1.500	6.66	-6.66	[0 - 1]
pegRatioTTM	-1.636	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.122	1.000	9.44	0	[0.1 - 0.5]
Total Score				4.83

Sisram Medical Ltd

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT brands. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.